Welcome to our dedicated page for Trinet Group SEC filings (Ticker: TNET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to TriNet Group, Inc. (NYSE: TNET) SEC filings, giving investors and analysts a primary source for the company’s regulatory disclosures. TriNet operates in human resources consulting services and describes itself as a provider of comprehensive, technology-enabled HR solutions for small and medium-size businesses, including human capital expertise, employee benefits, payroll and payroll tax administration, risk mitigation, and compliance consulting.
Through its periodic reports, TriNet details financial performance and operating metrics. Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K contain information on total revenues, professional service revenues, insurance service revenues, net income, Adjusted EBITDA, insurance cost ratios, and worksite employee statistics. These filings also expand on topics referenced in earnings press releases, such as non-GAAP measure reconciliations and management’s discussion and analysis of financial condition and results of operations.
Current Reports on Form 8-K document specific material events. Recent 8-K filings include announcements of quarterly financial results, reaffirmed full-year guidance, and dividend declarations with per-share amounts and key dates. Other 8-K filings describe executive leadership changes, such as the appointment of a new Chief Financial Officer, related employment agreements, equity award structures using restricted stock units and performance stock units, and participation in the company’s executive severance benefit plan.
TriNet’s filings also outline risk factors and regulatory considerations, including the risks associated with operating as a co-employer, managing workers’ compensation and health insurance costs, reliance on insurance carriers, exposure to economic conditions affecting SMB clients, and compliance with evolving data privacy, AI, and employment laws. These disclosures are intended to help market participants understand the uncertainties that may affect future results.
On Stock Titan, TriNet’s SEC filings are updated as they are made available through EDGAR, and AI-powered summaries can help explain the key points in lengthy documents such as 10-Ks, 10-Qs, and 8-Ks. Users can quickly identify major themes, track dividend and capital allocation decisions, and review executive compensation and governance-related information without reading every page of each filing.
TriNet Group, Inc. (TNET) notice reports a proposed sale under Rule 144 of 2,583 common shares held at Charles Schwab & Co., Inc., with an aggregate market value of $170,659.00 based on the filing. The filer lists 48,589,933 shares outstanding and an approximate sale date of 08/19/2025 on the NYSE. The shares were acquired on 08/15/2025 through a restricted stock lapse from TriNet Group, Inc. and are identified as equity compensation with payment dated 08/15/2025. The filer indicates no securities sold in the past three months and includes a representation that they do not possess undisclosed material adverse information.
TRINET GROUP, INC. (TNET) Form 4: Director Paul Edward Chamberlain sold 600 shares of the issuer's common stock on 08/07/2025 at a reported price of $64.18 per share. The filing states the sale was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 26, 2024. After the reported transaction, the reporting person beneficially owns 38,440 shares, a figure that the filer says includes unvested restricted stock units. The Form 4 was signed by an attorney-in-fact, Sheryl Southwick, on 08/11/2025. This disclosure records a routine insider sale under a prearranged plan and the remaining beneficial ownership reported by the director.
TriNet (TNET) Q2 2025 10-Q highlights: Total revenue was nearly flat at $1.24 B as 4% fewer average work-site employees (WSEs) were offset by higher pricing on professional and insurance services. Professional Service Revenue fell 8% to $172 M, while Insurance Service Revenue inched up 1% to $1.05 B. Rising medical utilization and specialty-drug spend lifted insurance costs 3%, pushing the Insurance Cost Ratio to 90% (vs. 88% LY). Operating expenses declined 2%, yet margin pressure drove income before tax down 37% to $51 M and net income down 38% to $37 M; diluted EPS slid to $0.77 from $1.20. Adjusted EBITDA dropped 23% to $105 M and margin narrowed to 8.5%.
Operational & liquidity points: Average WSEs fell 4% to 336,010 as client attrition and softer hiring hit the Technology, Professional Services, Main Street and Life Sciences verticals; co-employed WSEs declined 8% while platform-only users rose 56%. YTD operating cash flow improved 31% to $170 M, aiding a 13% rise in cash to $407 M and a 28% lift in corporate working capital to $254 M. Debt remained $984 M; the $90 M revolver balance was repaid in July. The company repurchased 1.23 M shares for $91 M (-92) and paid two $0.275 dividends, leaving $160 M available under its buyback authorization. Management continues a restructuring program (Q2 charge $2 M) and is assessing tax changes under the July 4 2025 OBBBA. All debt covenants were met.